Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by Craigbadon Oct 14, 2016 2:39pm
124 Views
Post# 25344697

RE:Shorty churned 1.2 MM shares to drop SP 20 cents

RE:Shorty churned 1.2 MM shares to drop SP 20 centsDo you think maybe Cibc's reduced target might be causing some selling? They basically said if you hold this there is 38% more downside. More downgrades to come i'm sure, but don't worry, its just short and distort. Lol

MirrorWorldMan wrote: What's it going to be next? 10 cents, then 5 cent. Then 2 cents? This isn't my first rodeo. At some point shorty will hit a concrete floor and try to cover after hours or maybe some dark pool (doubt it). I don't see evidence of manipulation for options strikes. It's just a solitary fund or two trying to stink up a stock. Hold all shares and shorty will start trading in multiples of 1/100 th of a cent to give the appearance of volume. Then earnings will start paying the bills and organic buying brings things upward in a slow painful way for shorty. Right now assets equals liabilities (roughly) and the future earnings need to pay debt expenses with some left over to chip away at the principals and sell some new drugs. Simple. Wait long enough and buy if you can. There is no evidence that creditors are getting nervous and there are new product revenues arriving to generate top line growth. MT stated the old drugs are not part of new revenue, they are cash cows. It's time for the new stars to take over as revenue drivers. But shorty by definition cannot see long term. 


<< Previous
Bullboard Posts
Next >>